every year 3 . Mortality from OHCA is high, with survival to discharge rates typically <10%.
Survival from OHCA is initially almost entirely dependent on pre-hospital eventsthe actions of lay bystanders, to initiate bystander cardiopulmonary resuscitation (CPR), and the emergency medical services to achieve return-of-spontaneous circulation (ROSC). Post-OHCA patients who arrive in the Emergency Department (ED) without spontaneous cardiac output rarely survive and transporting patients with ongoing resuscitation should be reserved for special circumstances (eg paediatric patients, hypothermic cardiac arrest). The focus of pre-hospital resuscitation must focus of good quality CPR and prompt defibrillation. Together with therapeutic hypothermia, these are the only three treatments shown in human trials to improve outcome from OHCA, as shown in Figure 1 .
Patients who achieve ROSC following OHCA have a high incidence of neurological impairment and cardiac failure. Post-ROSC strategies to improve survival from OHCA need to focus on limiting neurological and cardiac dysfunction. Despite advances in critical care medicine, in-hospital mortality for patients who achieve ROSC following OHCA remains high, with an in-hospital mortality of 71% in the UK 4 . Following ROSC, the only intervention shown in improving human survival and neurological outcome is mild therapeutic hypothermia (MTH).
The high mortality rate after OHCA results from multi-organ dysfunction, in particular post-arrest brain injury. This is the result of total body ischaemia and ischaemiareperfusion injury in addition to pathologies such as acute coronary artery occlusion that have often precipitated the initial cardiac arrest. The key elements of postresuscitation care include intensive care with multi-organ support, therapeutic hypothermia to reduce secondary injury, and coronary reperfusion therapy where appropriate to address the underlying precipitant. Care of OHCA is time sensitive and involves multiple specialties. It is becoming increasingly clear that this group of patients must be cared for by pre-hospital and hospital teams in a timely, collaborative manner in order to achieve optimal patient outcomes 5 .
Ambulance personnel should, therefore, consider transporting patients who achieve ROSC in the field following OHCA to centres who regularly receive OHCA patients and can offer immediate PCI and therapeutic hypothermia in an ICU-setting.
The History of Mild Therapeutic Hypothermia
Descriptions of hypothermia being used to treat patients have been documented for over 200 described OHCA patients being covered in snow, in the hope this would achieve ROSC 7 . Despite the possibility of therapeutic hypothermia showing promise in improving the poor survival rates from OHCA, it was largely abandoned until the 1990s, mainly due to is significant clinical side effects.
The concept of preserving the brain in the field, protecting it from hypoxia until the patient could be transported to hospital for spontaneous circulation to be restored or placed on cardiopulmonary bypass was first suggested by Peter Safar in 1984 8, 9 .
In 2002, two randomised trials demonstrated the benefit of cooling survivors of witnessed OHCA who had ventricular fibrillation (VF) as the presenting rhythm 10, 11 . Both of these trials used surface cooling and in the larger (European) trial, cooling was only commenced several hours after hospital admission. This lead to the International Liaison Committee on Resuscitation, the American Heart Association and the European Resuscitation Council recommending therapeutic hypothermia in the management of unconscious patients following OHCA 12, 13 . Despite these recommendations, the use of MTH is not yet routine 14 . Since 2002, multiple further trials have explored the use of therapeutic hypothermia for non-VF OHCA, traumatic cardiac arrests and in paediatric patients.
Therapeutic hypothermia in the pre-hospital setting
To date, there have been no published studies of therapeutic hypothermia initiated in the pre-hospital setting improving clinical outcome, despite some relatively large prehospital clinical trials being undertaken 15, 16 . Most of these trials have used cold intravenous saline to cool the patient, although recently intra-nasal cooling has shown promise when used during resuscitation ie pre-ROSC. Therapeutic hypothermia should not distract ambulance personnel from the basics of resuscitation. In settings where transport-to-hospital times are short, commencing cooling on arrival at hospital is probably sufficient. Only when transport-to-hospital times are prolonged should consideration be given to prehospital cooling. The concept of the "time window" for therapeutic hypothermia is discussed below. Further research is required on the value of intra-arrest cooling.
How does cooling work?
The exact mechanisms through which therapeutic hypothermia confers survival benefit and neurological protection are not known. Cooling is known to reduce cerebral metabolism, reducing the amount of oxygen required by the brain. Post-ROSC, a series of complex ischaemia-reperfusion cascades occur as pro-inflammatory cytokines cause a secondary brain injury. This cascade lasts hours to days and is known to be limited by cooling. Post-ROSC, it is likely that a "window of cooling" opportunity of up to 4-hours post-ROSC exists during which time therapeutic hypothermia will exert its effects. Cooling earlier in this window has not yet been shown to be more beneficial. Cooling pre-ROSC is the focus of several current trials. A summary of how cooling exerts protective effects is shown in Figure 2 .
Clinical application of therapeutic hypothermia
Therapeutic hypothermia (32-34ºC) is recommended for patients who remain comatose after OHCA. Hypothermia improves survival and neurological outcome in patients with witnessed OHCA with ventricular fibrillation (VF) as the presenting cardiac rhythm 17, 18 . Therapeutic hypothermia is most commonly initiated in the ICU but earlier cooling may be beneficial 19, 20 . In addition, for OHCA patients with STsegment elevation on the post-ROSC electrocardiogram undergoing immediate coronary angiography, cooling prior to balloon inflation in the catheter laboratory can reduce cardiac infarct size 21, 22 . In view of these findings, therapeutic hypothermia should be initiated as early as possible for patients with STEMI, and certainly not delayed until after primary percutaneous coronary intervention (PCI). Cooling is likely to be delayed if not commenced in the Emergency Department 23 . Traditionally, therapeutic cooling has been accomplished by two methods: external cooling, by the use of cold packs and cooling blankets, and internal cooling, using cold intravenous infusions and, more recently, indwelling catheters. These methods are relatively slow to achieve target temperature. The different cooling modalities are shown in Table 1 . 
Cooling during resuscitation
A novel approach to hypothermia induction is the use of a nasopharyngeal device (RhinoChill; BeneChill Inc.) that facilitates brain and core-body cooling. This cooling technique involves delivering a coolant in spray form using an oxygen flow rate of 40 L/min, resulting in a coolant delivery rate of 32 mL/min. It is safe, and effective in cooling patients post-OHCA 24 with a rapid reduction in core body temperature. Intra-nasal cooling may be especially beneficial when used during CPR. Animal research shows cooling during this period confers the greatest survival benefit and brain protection. Current clinical trials are exploring this concept. The Rhinochill device is shown in Figure 1 .
There is strong evidence to support the use of therapeutic hypothermia in comatose patients after OHCA whose initial cardiac rhythm was VF. Cooling in other rhythms is likely to be beneficial as well. Despite animal studies demonstrating the benefit of immediate cooling, either during CPR or immediately post ROSC [25] [26] [27] , the existing evidence from human studies is less clear 28 . Practically, initiating cooling in the prehospital environment is challenging, however several studies have shown that initiating cooling in the field or in the ED is feasible and effective [29] [30] [31] , but survival benefit has yet to be proven.
The use of ice packs is a simple, but relatively slow, means of cooling. A bolus of cold intravenous fluids combines efficacy with ease of use and is not associated with significant unwanted side effects. This is probably the cooling method of choice for the Emergency Department and possibly pre-hospital use. Intravenous fluids can be stored in a refrigerator or cool box within the ED/ambulance and administered to post-OHCA patients shortly after arrival in hospital. Recent studies, however, have failed to show that initiating cooling in the prehospital phase improves outcome when the transfer-to-hospital times are short 16. Initiating cooling in the ED is likely to shorten the time-to-target temperature time, particularly if the patient requires coronary intervention or radiological imaging prior to Intensive Care Unit admission. Cooling with cold intravenous fluids can continue during transfer or during clinical procedures.
The three phases of therapeutic hypothermia include induction, maintenance and rewarming. For all phases, accurate core body temperature measurement is essential to ensure accurate cooling and prevent over cooling. For rapid induction, oesophageal or central venous temperature should be measured as probes in the bladder or rectum not reflect core body temperature accurately 32 . Overcooling is common 33 . After induction, therapeutic hypothermia can be maintained on the ICU with body surface cooling techniques with accurate feedback mechanisms, or invasive, endovascular cooling techniques. In order to prevent shivering, paralysis and sedation are required. The optimum length of time for which MTH should be maintained remains unknown 34, 35 but previous studies have maintenance periods of 24-48 hours 36, 37 .
It is imperative that pre-hospital services transport post-OHCA patients to hospitals routinely used to performing emergency PCI, initiating cooling and maintaining therapeutic hypothermia for 24-hours.
Emergency Preservation Resuscitation (EPR)
EPR is an innovative development in the resuscitation of OHCA patients. Patients suffering an OHCA who fail to have circulation restored by emergency medical services using conventional resuscitation techniques almost invariably die. Many of these patients have an acute coronary artery occlusion as a potentially reversible cause of cardiac arrest and death. Pilot studies have demonstrated the feasibility of placing OHCA patients who fail to achieve ROSC at scene on continuous CPR, usually a mechanical device (e.g. AutoPulse or LUCAS), initiate therapeutic hypothermia and use an extra-corporeal membrane oxygenation circuit (ECMO) and an intraaortic balloon pump to maintain cerebral oxygenation and perfusion 38, 39 . The patient can then be transported for immediate coronary intervention, where revascularisation may result in ROSC. This approach has been effectively demonstrated in animals, with neurologically intact survival possible with periods of cardiac arrest of over an hour 40, 41 . Performing coronary intervention on patients whilst being treated with ECMO is feasible 42, 43 and although this technique is still very novel, it promises to improve survival 44,4 5.
Key Messages
Quality of CPR is paramount in any resuscitation attempt.
All OHCA patients with a presumed cardiac origin, regardless of initial cardiac rhythm, should be cooled.
There is no current evidence to support pre-hospital cooling when transport-tohospital times are short.
OHCA patients who achieve ROSC should be transported to centres capable of performing immediate PCI and commencing cooling simultaneously.
OHCA patients who achieve ROSC should be cooled for at least 24-hours.
Further research is warranted to establish the value of novel cooling techniques, eg intra-nasal cooling and intra-arrest cooling. Castren M, Nordberg P, Svensson L, Taccone F, Vincent JL, Desruelles D et al. Intra-Arrest Transnasal Evaporative Cooling: A Randomized, Prehospital, Multicenter Study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation 2010; 122(7):729-736. (25) Zhao D, Abella BS, Beiser DG, Alvarado JP, Wang H, Hamann KJ et al. Intra-arrest You can also subscribe free of charge to receive Ambulance Today on an ongoing basis as a free download direct to your mail box by clicking on the 'Subscribe to the Online edition' box also on the home page.
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